Last reviewed · How we verify

NCT04091555

Evaluation of the Impact of the HL Natural, Inc. Tension Relief Product

Completed NA Last updated 15 November 2021
What this trial tests

NA trial testing HLNatural Tension in Tension in 117 participants. Completed in 16 September 2020.

Timeline
16 October 2019
Primary endpoint
16 August 2020
16 September 2020

Quick facts

Lead sponsorHawthorne Effect Inc.
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeother
Enrollment117
Start date16 October 2019
Primary completion16 August 2020
Estimated completion16 September 2020
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Hawthorne Effect Inc.

Who can join

18 and older, any sex, with Tension or Headache. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary hypothesis of the present study is that supplementation with the Tension Relief test product will reduce the severity of symptoms of a tension headache.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Hawthorne Effect Inc. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04091555.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing